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Abstract 
Purpose: To carry out a post-marketing evaluation of the stability and drug dissolution of Qingkailing 
soft/hard capsules. 
Methods: High performance liquid chromatography with diode array detection (HPLC-DAD) method 
was developed for the determination of three key ingredients (chlorogenic acid, geniposide and baicalin) 
and fingerprints of QKL soft/hard capsules. Stability tests were carried out based on long-term testing. 
The drug release profile of Qingkailing soft and hard capsules were studied using semi-bionic incubation 
experiments. 
Results: The linearity, precision, stability, repeatability and recovery of HPLC and fingerprint all met the 
requirements of CFDA. Stability data from long-term studies showed that within 6 months the contents 
of the three key ingredients in both soft and hard capsules remained > 90 %. However, fingerprint 
pattern statistical analysis showed that the soft capsule is more stable than the hard capsule. 
Furthermore, the key ingredients of the hard capsule dissolved much faster (p < 0.05) than from the soft 
capsule. The level of dissolved drug of hard capsule is about 4 times the rate of soft capsule, after a 4-h 
incubation in gastric lavage fluid. In intestinal lavage fluid, more than 90 % of chlorogenic acid, 
geniposide and baicalin of hard capsule were dissolved in 2 h, while the soft capsule displayed a 12 h 
sustained release. Fingerprint pattern statistical analysis also showed that most of the components of 
soft capsule dissolved after 8 h.  
Conclusion: Compared with the hard capsule, Qingkailing soft capsule has certain advantages in 
stability and drug dissolution, which may affect the biopharmaceutics and the clinical effects of the drug. 
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Qingkailing (QKL) is a famous herbal compound 
prescription in China, which consists of Radix 
isatidis, Flos lonicerae, Fructus gardeniae, Bubali 
cornu, Concha margaritifera, baicalin, cholic acid 
and hyodeoxycholic acid. QKL injection is widely 
used clinically for the treatment of 
cerebrovascular ischemic disease, ardent fever, 
hepatitis, pneumonia, H1N1, and avian influenza. 
However, with the increase of ADR cases 
reported these years [1], capsule is favored by 
more and more patients and doctors in China. 
There are two marketed forms of QKL capsules 
in China, hard and soft capsule, with annual 
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sales exceeding RMB 1 billion (US$ 0.15 billion) 
in 2016.  
 
A previous study has shown that the 
bioavailability of baicalin in soft capsule is higher 
than that of hard capsule [2]. Compared with 
hard capsule, soft capsule had a longer mean 
residence time (MRT), a higher maximum 
concentration (Cmax), and a larger area under the 
curve (AUC). The improvement may be caused 
by the dosage form. Soft capsule may be more 
beneficial to the stability of the active ingredients 
both in vitro and in vivo. The drug dissolution 
behavior may also affect the pharmacokinetic 
behavior in vivo. 
 
Therefore, the purpose of this study was to 
evaluate the stability and the drug dissolution 
behavior of the two capsules by long-term 





Materials and processing software 
 
Standards of chlorogenic acid, baicalin and 
geniposide were obtained from National 
Institutes for Food and Drug Control (Beijing, 
China); methanol, acetonitrile and phosphoric 
acid of HPLC grade were obtained from Thermo 
Fisher Scientific Inc. (USA); pure water of HPLC 
grade was purchased from Wahaha (Hangzhou 
Wahaha Group Co.,Ltd.); QKL soft capsules 
were offered by Shineway Pharmaceutical Group 
Co. Ltd in China (batch number: 14072411), QKL 
hard capsule were offered by Guangzhou 
Baiyunshan Mingxing Pharmaceatical Co. Ltd in 




Male Sprague-Dawley rats (220 – 250 g) of SPF 
grade were purchased from Vital River 
Laboratory Animal Technology Co. Ltd, China. 
Before experiment, the animals were fasted 24 
hours, with free access to water. The 
experimental protocols were conducted in 
accordance with The Guiding Principles for the 
Care and Use of Laboratory Animal [3] in China. 
Experimental protocols were approved by the 
institutional animal experimentation committee of 
Beijing University of Chinese Medicine (approval 
ref. no. : Kj-dw-18- 20150923-01). 
 
The fingerprint data were processed by principal 
component analysis (PCA) using SIMCA-P 11.5 
software (Umetrics AB, Sweden). 
 
Evaluation of long-term stability of soft and 
hard capsules 
 
The soft/hard capsules were placed for 0, 1, 2, 3, 
6 month as stated in Chinese Pharmacopoeia. 
The test was carried out at the beginning of each 
month. Three key ingredients (chlorogenic acid, 
geniposide and baicalin) were determined 
according to the method established. 
 
Pretreatment of QKL soft capsules 
 
Oily content (0.4 g) of QKL soft capsules was 
absorbed by diatomite (1.2 g) and the mixture 
was transferred into a flask (25 ml) and solvent 
(acetonitrile: 0.08 % phosphoric acid, 39:61) was 
added in to volume. The flask was then weighted 
accurately followed by ultrasonic extraction (200 
w, 49 kHz, 70 min). After that, the same solvent 
was added in to make up the solvent loss caused 
by ultrasonic extraction. A portion of this solution 
was centrifugated for 10 min (10,000 rpm). Then 
pass the supernatant through a filter having a 
0.45-μm porosity, and use the filtrate after 
discarding the first 2 ml. Two samples were 
prepared by the same method at a time. 
 
Pretreatment of QKL hard capsules 
 
Transfer an accurately weighed portion of the 
powder (0.5 g) of hard capsules to a 25-ml flask, 
solvent (acetonitrile: 0.08 % phosphoric acid, 
39:61) was added in to volume. The flask was 
weighted accurately followed by ultrasonic 
extraction, the remaining steps were the same as 
soft capsule group. Two samples were prepared 




The fingerprint of the two capsules was studied 
according to the Technical Requirements of 
Fingerprint Research on Traditional Chinese 
Medicine Injection [4], which is made by CFDA. 
Baicalin, the highest peak, was chosen as the 
reference peak. The precision, stability and 
repeatability were studied and were all met the 
requirements of the guidance. 
 
Drug dissolution studies by semi-bionic 
incubation methods 
 
Simulated gastric fluid (SGF) and simulated 
intestinal fluid (SIF) were prepared according to 
Chinese Pharmacopoeia [5]. Preparation of 
gastric lavage fluid: Rats fasted 24 h with free 
access to water. They were anaesthetized by 20 
% urethanes (2 ml) and placed on a hot pad to 
maintain normal body temperature. An 
abdominal midline incision was made. Then 
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semi-circular incisions were made at the ends of 
stomach. PE tubes were inserted into cardia and 
pylori respectively and then ligated with silk 
sutures. Stomach was lavaged with 15 ml SGF 
(37 oC). The lavage fluid of 3 rats (about 40 ml) 
was collected into a 50 ml flask and then dilute 
with SGF to volume, and mix. 
 
Preparation of intestinal lavage fluid: Rats were 
anaesthetized and were celiotomized. Semi-
circular incisions were made at the fore-end of 
duodenum and back-end of ileum. PE tubes 
were inserted in and ligated with silk sutures. 
Small intestine was lavaged with 40 ml SIF (37 
℃). The lavage fluid was collected into a 50 ml 
flask and then dilute with SIF to volume, and mix. 
 
Drug dissolution in gastric lavage fluid: Place 50 
ml gastric lavage fluid in a triangular flask, 
equilibrate the dissolution medium to 37 ℃ in a 
constant temperature shaker. Place QKL soft 
capsule (or hard capsule) in the triangular flask. 
At each of the test-time points (1, 5, 10, 30, 60, 
90,120 and 240 min), withdraw a specimen (1 
ml) from the triangular flask. And replace the 
aliquots withdrawn for analysis with equal 
volumes of fresh dissolution medium at 37 oC. 
Sodium hydroxide solution (0.1 mol/l, 400 μl) was 
added into the withdrawn as the neutralizer. 
Then, add 2 ml of methanol to precipitate the 
pepsin.  
 
The mixture was vortexed for 3 min and then 
centrifuged for 10 min (10,000 rpm). Pass the 
supernatant through a filter having a 0.22-μm 
porosity, and use the filtrate after discarding the 
first 0.5 ml as the test solution. Inject 20 μl test 
solution into the chromatograph, record the 
chromatograms, and measure the peak 
responses. Six dosage units were tested by the 
same method at a time. The amount of dissolved 
drug Q (expressed as a percentage of the 
labeled content of the dosage unit) was 









    ………… (1) 
 
where Cn is the drug concentration of the nth 
time point (mg/ml); Ci is the drug concentration in 
flask of the ith (i ≤ n-1) sampling point; D is the 
content of the dosage unit.  
 
Drug dissolution in intestinal lavage fluid: Both 
hard capsule and soft capsule broke in the 
gastric lavage fluid in a few minutes. In this 
study, the contents of capsules (instead of 
capsules) were incubated with intestinal lavage 
fluid (50 ml). The test-time points were 0.083, 
0.25, 0.5, 1, 1.5, 2, 4, 6, 8, 12, 18, 24 h. At each 
of the time stated, withdraw a specimen (1 ml) 
from the triangular flask. Then, add 2 ml of 
methanol to precipitate trypsin, the remaining 
steps were the same as gastric lavage fluid 
group. The amount of dissolved drug Q was 









    ……………… (2) 
 
where Cn is drug concentration of the nth time 
point (mg/ml); Ci is the drug concentration in 
flask of the ith (i ≤ n-1) sampling point; D is the 
content of the dosage unit. 
 
The linearity, precision, stability, repeatability and 
recovery of chlorogenic acid, geniposide, baicalin 
were studied according to General Requirements 
of Chinese Pharmacopoeia [5]. The fingerprint 
methodology was studied according to Technical 
Requirements of Fingerprint Research on 
Traditional Chinese Medicine Injection [4]. And 




The separation conditions were carried out on a 
Phenomenex Luna RP18 column (250 × 4.6 mm 
i.d., 5 μm), the temperature was set at 30 ℃. 0.4 
% phosphoric acid in water (phase A) and 
methanol-Phosphoric acid (4:1) (phase B) were 
used as mobile phase under the gradient elution 
mode: A:B (v/v) 95:5 (0 min); 70:30 (15 min); 
65:35 (22 min); 40:60 (40 min), 40:60 (43 min); 
19:81 (55 min); 10:90 (60 min), and 10:90 (65 
min).  
 
The flow rate was set at 1.0 ml/min. A DAD 
detector was used for detection, and the 
wavelength was set at 327 nm (for chlorogenic 
acid), 240 nm (for geniposide), 278 nm (for 




The contents of three key ingredients were 
calculated according to the peak responses of 
standards and samples. Data of soft capsule and 
hard capsule groups were analyzed by Student’s 
test with p < 0.05 set as statistically different. 
 
Fingerprint data of different capsules or different 
sampling time points were imported to SIMCA-P 
(version 11.5) software and were processed by 
principal component analysis (PCA). It is a well-
known chemometric method for the decompo-
sition of two-dimensional matrices. Loading Bi 
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Long-term stability comparison between soft 
and hard capsules based on multi-component 
quantification 
 
The contents of chlorogenic acid, geniposide and 
baicalin in hard capsule and soft capsule were 
determined. The contents of three key 
ingredients remained were shown in Figure 1. As 
was shown in the picture, these key ingredients 
degraded slowly in the past 6 months in both soft 
and hard capsules, but they all remained > 90 %. 
No differences were observed (p > 0.05). 
 
 
Figure 1: Long-term stability test of 3 key ingredients 
in QKL soft/hard capsules. A = chlorogenic acid; B = 
geniposide; C = baicalin; △: soft capsule; ▲: hard 
capsule 
 
Long-term stability of soft and hard capsules 
based on fingerprint pattern analysis 
 
There are many other ingredients in this herbal 
compound prescription. There were 21 common 
peaks (their peak areas account for 87.42 % of 
all peaks areas) and 16 common peaks (their 
peak areas account for 84.59 % of all peaks 
areas) were identified in soft and hard capsules 
samples (11 batches for each capsule), 
respectively. 
 
PCA was used to evaluate the stability of two 
capsules integrally. Fingerprint data of QKL 
soft/hard capsules were imported in software 
SIMCA-P 11.5. And PC1 could explain nearly 
100 % of variance. 
 
 
Figure 2: PCA scatter plot of QKL soft and hard 
capsules. ▲: hard capsules of different month ; △: soft 
capsules of different month 
 
The PCA scatter plot (PC1 versus PC2) was 
shown in Fig 2. The samples of soft capsules of 
0, 1, 2, 3, 6 month (two samples for each time 
point) were clustered together. But, the samples 
of hard capsules were clearly divided into two 
groups, which indicated that samples of 6 month 
were quite different from the other samples of 
hard capsule. 
 
Drug dissolution of QKL soft and hard 
capsules in gastric lavage fluid 
 
QKL soft and hard capsules ruptured in no more 
than 15 minutes and 1 minute, respectively. As 
was shown in Figure 3, for hard capsule, not less 
than 50 % (Q) of the chlorogenic acid and 
geniposide were dissolved in 15 min, and they 
kept growing in the next 225 min. But the Q of 
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baicalin decreased after a fast dissolution in the 
first 15 min.  
 
For soft capsule group, the Q of three ingredients 
kept growing in 240 min, and finally reached 7.32 




Figure 3: Drug dissolution of 3 key ingredients of QKL 
soft/hard capsules in gastric lavage fluid. A = 
chlorogenic acid; B = geniposide; C = baicalin; △: soft 
capsule; ▲: hard capsule 
 
Drug dissolution of QKL soft and hard 
capsules in intestinal lavage fluid 
 
Compared with gastric lavage fluid group, 
different dissolution behavior was observed in 
intestinal lavage fluid. As was shown in Figure 4, 
for hard capsule, not less than 90 % of 
chlorogenic acid, geniposide and baicalin were 
dissolved in 2 h. Then, they all declined gently (to 
about 80 %).  
 
However, for soft capsule, whose dissolution 
behavior is quite different, the Q of 3 ingredients 
kept growing up to 95.18 % (chlorogenic acid), 
93.18 % (geniposide), 99.31 % (baicalin) in 12 h. 
And they were stable in the following 12 h (with a 




Figure 4: Drug dissolution of 3 key ingredients of QKL 
soft/hard capsules in intestinal lavage fluid. A = 
chlorogenic acid; B = geniposide; C = baicalin; △: soft 
capsule; ▲: hard capsule 
 
Drug dissolution of QKL soft capsules in 
intestinal lavage fluid based on fingerprint 
pattern analysis 
 
As shown in Figure 3 and Figure 4, the key 
ingredients were unstable when hard capsules 
were incubated with gastric lavage fluid and 
intestinal lavage fluid. The degradation may 
affect the analysis based on fingerprint pattern 
statistical analysis. However, soft capsule can 
keep the ingredients stable in intestinal lavage 
fluid, the Q of 3 ingredients were kept at about 95 
% finally. So, drug dissolution behavior of soft 
capsule in intestinal lavage fluid based on 
fingerprint pattern analysis was studied.  
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PCA was also used to evaluate the drug 
dissolution behavior of soft capsules integrally. 
Fingerprint data of QKL soft capsules were 
imported in software (six samples for each time 
point). 
 
For soft capsules, three principal components 
affecting the dissolution behavior were identified 
with a cumulative score 43.7 %. The loading Bi 
Plot (PC1 versus PC2) was shown in Figure 5. 
Chromatogram peaks (△) close to the time points 
(■) contribute the most to the differentiation of 
the samples of different sampling time, which 
indicated that, for soft capsule, peak 11, 18, 19, 
23, 24, 26, 31, 32, 41, 46, 74 dissolved before 1 
h, peak 8, 25, 28, 30, 40, 43, 59 dissolved from 
1.5 to 2 h, peak 2, 4, 6, 7, 10, 15, 17, 20, 29, 33, 
34, 37, 38, 42, 44, 47, 49, 51, 56, 58, 62, 70, 71, 
73 dissolved from 2 to 4 h, the other peaks 
dissolved after 6 h. 
 
 
Figure 5: Loading Bi Plot of QKL soft capsules’ 
dissolution behavior in intestinal lavage fluid. ■: 
different time points for sampling (0.083, 0.25, 0.5, 1, 
1.5, 2, 4, 6, 8, 12, 18, 24 h); △: Chromatogram peaks 




The key ingredients of QKL soft/hard capsules 
had good stability in vitro within 6 months. The 
contents of chlorogenic acid, geniposide and 
baicalin remained > 90 %. 
 
Saline, SGF or SIF are commonly used as the 
mediums in drug dissolution studies. However, 
besides pepsin and trypsin, there are many kinds 
of enzymes and intrinsic factors in stomach and 
small intestine, which may also affect the 
metabolism of drugs. In this study, we prepared 
gastric lavage fluid and intestinal lavage fluid as 
the mediums of drug dissolution. 
 
In gastric lavage fluid, for hard capsule, three key 
ingredients dissolved quickly. But baicalin 
degraded after 15 minutes, which might be 
caused by pepsin and pH of the environment [6]. 
For soft capsule, the Q of three ingredients kept 
growing in the whole sampling time. 
 
In intestinal lavage fluid, for hard capsule, the Q 
of 3 key ingredients reached 90 % in 2 hours. But 
then, they all decreased to about 80 %. For soft 
capsule, sustained release behaviors were 
observed in 12 hours and the Q of three 
ingredients has been maintained. The oily 
accessories may protect the ingredients from 
degradation caused by enzymes, and OH-. 
Besides, the sustained release of the drug may 
also increase the bioavailability, in previous study 
[2]. 
 
Compared with chemical drug, traditional 
Chinese medicine (or herbal medicine) is 
characteristic of multi-component with multi-
target, which brings a great challenge for quality 
control [7]. Usually, some components are 
chosen as indicators for quality control, however, 
they can hardly express the information of the 
preparation fully. Pattern recognition analysis in 
combination with fingerprint can provide a visual, 
simple and valid method for quality control of 
traditional Chinese medicine [8]. Integrated 
evaluation based on pattern recognition analysis 
can achieve a comprehensive analysis for 
multidimensional information of traditional 
Chinese medicine and has been used on study 
of Chinese material medica [9,10], like producing 
area[11], taxa of medicinal plant [12] and quality 
control of traditional Chinese medicine injections 
[13].  
 
PCA (Principal Component Analysis) is a method 
of multivariate statistical analysis for integrated 
evaluation. A collection of observations of 
possibly correlated variables are transformed in 
to a set of values of linear uncorrelated variables 
(usually, the number of these new variables is 
less than that of the original variables), which 
were considered as principle components. The 
first principal component could explain as much 
of the variability in the data as possible. Each 
subsequent component also has the highest 
variance with the constraint that it is orthogonal 
to the preceding components. Finally, an 
orthogonal basis set with uncorrelated vectors 
was obtained. 
 
Consider a data matrix, X, its rows is fulfilled with 
peak areas of chromatography at different time, 
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its columns is described by different samples. 
For example, Eq 1 is our original observation 
matrix: 
 
X =  …………… (3) 
 
In this matrix, m random variables  
form a vector of m dimensions. That is, 
. Its mean vector is denoted 
by , its covariance is denoted by . Consider 




It can be written as the product of matrix: 
 
 …………………. (5) 
 
where , and  
 
 …………… (6) 
 
As mentioned above, PCA is considered as a 
linear transformation method which can 
transform original data to a new coordinate 
system. The greatest variance by some 
projection of the data comes to lie on the first 
coordinate (called the first principal component), 
the second greatest variance on the second 
coordinate, and so on [14]. Thus we know that 
the problem to obtain the principal component is 
to find a linear function  of variable  such 
that the variance of  could be as large as 
possible. That is, we need  
 
 
                    
                    …………. (7) 
 
reach its maximal value. And we have two 
constraint conditions. First, we need 
 
 ……….. (8) 
 
to avoid . 
 
Second, we want each of principal components 
 are uncorrelated. We need  
 
 
……. (9)    
 
Under these constraint conditions, we know that 
principal components achieve their maximal 
value when  is the eigenvector of  and the 
eigenvalue of  is the variance of principal 
components.  
 
Assume there are m eigenvalues of : 
, and  denotes 
corresponding normalized orthogonal 





Then the ith principal component is given by the 
following: 
 
 ……. (11) 
 
After getting the principal components, we can 
do some cluster analysis of our samples. 
Observe the crucial samples of each principal 
component, If  and  have superior 
contribution rate for , and their contribution rate 
are close, we could conclude that they should be 
clustered. The computing process can be 
conducted by software SIMCA-P. 
 
In our study of long-term stability, samples of soft 
capsules of different month were clustered 
together. Meanwhile, the samples of hard 
capsules were divided into two cluster, the 
samples of 6th month are far from the other 
samples, which indicates that the fingerprint of 
hard capsule has changed a lot in 6th month. To 
some extent, soft capsule is more stable than 
hard capsule. 
 
In the study of drug dissolution evaluation, 
samples of different time were taken as the 
columns of the matrix. To understand which 
components contributed to the differentiation, a 
Loading Bi-plot, which presented all key items 
(samples of different time and chemical 
components represented by different peaks) in 
one picture to demonstrate the relationships 
among them, was investigated. In this plot, 
samples (represented by diamonds) in close 
proximity to components (represented by 
triangles) have high levels of these component, 
and the components away from the sample 
symbols are low in these samples.  
 
In general, the proximity between the sample 
symbols and component symbols indicates their 
correlation. Therefore, this Bi-plot showed that 
most of the components (peaks) are positively 
correlated with the samples from 6 h to 24 h, 
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which indicated the sustained release behavior of 
the soft capsule. For soft capsule, an O/W 
emulsion may be formed by the protein in 
intestinal lavage fluid with gently shaking. The 
indicators (chlorogenic acid, geniposide and 
baicalin) dispersed in the oily accessories were 
kept stable and the other components were 
released slowly. Previous study showed that the 
bioavailability of baicalin in soft capsule is higher 
than that of hard capsule, which may be also 
caused by the protection and absorption 




QKL soft capsule displayed better stability than 
the hard capsule both in vitro and in semi-bionic 
condition. The soft capsule also displayed 
sustained release behavior, and thus, may also 
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